Factor | Berge_2006_AppandEnvMic (10249)

10.1128/AEM.02239-05

Antimicrobial Therapy

Cattle | Pre-weaned Calves

11

Description

Group 2 vs Group 3 (see Table 1 for criteria for clinical diagnosis and specific Ams available). Both groups were housed on a calf ranch. Data is from Day 14.

Resistance Outcomes

Resistance Microbe Outcome
Ampicillin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 44 72
Group 3 (antimicrobial therapy available) 58 84
Cefalotin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 15 72
Group 3 (antimicrobial therapy available) 47 84
Ceftiofur
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 14 72
Group 3 (antimicrobial therapy available) 47 84
Amikacin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 0 72
Group 3 (antimicrobial therapy available) 4 84
Gentamicin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 13 72
Group 3 (antimicrobial therapy available) 27 84
Streptomycin
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 50 72
Group 3 (antimicrobial therapy available) 64 84
Sulfafurazole
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 48 72
Group 3 (antimicrobial therapy available) 61 84
Sulfamethoxazole And Trimethoprim
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 27 72
Group 3 (antimicrobial therapy available) 33 84
Tetracycline
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 53 72
Group 3 (antimicrobial therapy available) 78 84
Chloramphenicol
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 10 72
Group 3 (antimicrobial therapy available) 27 84
Nalidixic Acid
/
Escherichia coli
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 2 (no antimicrobial therapy available) 0 72
Group 3 (antimicrobial therapy available) 0 84